Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 sing...

FDA Recall #D-001-2014 — Class II — October 24, 2013

Recall #D-001-2014 Date: October 24, 2013 Classification: Class II Status: Terminated

Product Description

Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO 64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30, UPC 3 68546 31730 4.

Reason for Recall

Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.

Recalling Firm

Teva Pharmaceuticals USA — Horsham, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

6,803 cartons

Distribution

Nationwide

Code Information

Lot X06381, Exp 10/14

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated